Clinical trial
Impact of E-reporting by Patients With Relapsing-remitting Multiple Sclerosis on the Reporting of Adverse Drug Reactions in France: a Randomized Controlled Trial.
NCT03029897 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of E-reporting by Patients With Relapsing-remitting Multiple Sclerosis on the Reporting of Adverse Drug Reactions in France: a Randomized Controlled Trial.
- Lead sponsor
- University Hospital, Caen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 5, 2017
- Completion date
- April 24, 2019
- Enrollment
- 161 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.